CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 113 enrolled
Drug / intervention
Intravenous Fluid Capother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03137446
NCT03137446N/ACompleted
CompareCT.gov

Assessing Targeted Fluid Resuscitation Strategies Among Patients With Severe Sepsis and Septic Shock

Rhode Island Hospital·interventional·Posted May 2, 2017·Updated Aug 31, 2018

In Brief

A clinical study evaluating Intravenous Fluid Cap for Septic Shock and Severe Sepsis. Completed, enrolled 113 participants across 1 site.

Detailed Summary

IV fluid resuscitation has long been recognized to be an important treatment for patients with severe sepsis and septic shock. While under-resuscitation is known to increase morbidity and mortality, contemporary data suggests that overly aggressive fluid resuscitation may also be harmful. Currently, following an initial IVF resuscitation of 30 ml/kg, there is no standard of care and a lack of evidence to support a fluid restrictive or more liberal strategy. The investigators seek to determine if a fluid restrictive strategy reduces morbidity and mortality among patients with severe sepsis and septic shock.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSeptic Shock, Severe Sepsis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 2, 2017
Enrollment StartApr 20, 2017
Primary CompletionMar 30, 2018
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 9.2 years ago

Interventions

Intravenous Fluid Capother

Normal Saline or Ringers Lactate limited to 60ml/kg for first 72 hours